Cargando…

The Effect of Antivascular Endothelial Growth Factor Therapy on the Development of Neovascular Glaucoma after Central Retinal Vein Occlusion: A Retrospective Analysis

Purpose. Ischemic central retinal vein occlusion (CRVO) eyes are at high risk of developing neovascular glaucoma (NVG). Our purpose is to investigate the effect of anti-VEGF therapy for macular edema after CRVO on the development of neovascular glaucoma (NVG) in ischemic CRVO eyes. Methods. This is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ryu, Christina L., Elfersy, Adrian, Desai, Uday, Hessburg, Thomas, Edwards, Paul, Gao, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995099/ https://www.ncbi.nlm.nih.gov/pubmed/24800060 http://dx.doi.org/10.1155/2014/317694

Ejemplares similares

Neovascular glaucoma after central retinal vein occlusion in pre-existing glaucoma
por: Chen, Hsi-Fu, et al.
Publicado: (2014)

Antivascular Endothelial Growth Factor Dosing Frequency and Visual Outcomes in Macular Edema Following Central Retinal Vein Occlusion
por: Modi, Yasha S., et al.
Publicado: (2021)

Neovascular Glaucoma Due to Branch Retinal Vein Occlusion Combined with Branch Retinal Artery Occlusion
por: An, Tae-Su, et al.
Publicado: (2013)

Central retinal thickness changes and risk of neovascular glaucoma after intravitreal bevacizumab injection in patients with central retinal vein occlusion
por: Lee, You Hyun, et al.
Publicado: (2022)

Comparative efficacy and safety of antivascular endothelial growth factors for central retinal vein occlusion: A protocol for systematic review and network meta-analysis
por: Liu, Zhigao, et al.
Publicado: (2021)

Intravitreal Bevacizumab in the treatment of neovascular glaucoma secondary to central retinal vein occlusion: a case report
por: Alasil, Tarek, et al.
Publicado: (2009)

Antivascular endothelial growth factor for macular oedema secondary to retinal vein occlusion: a systematic review and meta-analysis
por: Xu, Shanshan, et al.
Publicado: (2022)

Intravitreal Bevacizumab for the Treatment of Neovascular Glaucoma Associated With Central Retinal Artery Occlusion
por: Sagong, Min, et al.
Publicado: (2009)

Full-thickness macular hole formation following antivascular endothelial growth factor injection in a case of hemicentral retinal vein occlusion
por: Mitra, Srijita, et al.
Publicado: (2021)

Comparing vision and macular thickness in neovascular age-related macular degeneration, diabetic macular oedema and retinal vein occlusion patients treated with intravitreal antivascular endothelial growth factor injections in clinical practice
por: Gurung, Rajya L, et al.
Publicado: (2021)

Antivascular Endothelial Growth Factor Agents for Neovascular Age-Related Macular Degeneration
por: Zampros, Ilias, et al.
Publicado: (2012)

Changes in Macular Microvascular Structure in Macular Edema Secondary to Branch Retinal Vein Occlusion Treated with Antivascular Endothelial Growth Factor for One Year
por: Song, Shuang, et al.
Publicado: (2021)

Herpes Zoster Ophthalmicus, Central Retinal Artery Occlusion, and Neovascular Glaucoma in an Immunocompetent Individual
por: Ahmad, Syed Shoeb, et al.
Publicado: (2019)

Neovascular Glaucoma Complicating Central Retinal Artery Occlusion Despite Cilioretinal Artery Sparing
por: Zakaria, Nur Aisyah, et al.
Publicado: (2023)

Safety of antivascular endothelial growth factor administration in the ocular anterior segment in pterygium and neovascular glaucoma treatment: Systematic review and meta-analysis
por: Huang, Shi-tong, et al.
Publicado: (2018)

Branch Retinal Vein Occlusion followed by Central Retinal Vein Occlusion
por: Moradian, Siamak, et al.
Publicado: (2009)

Concurrent management of myopic choroidal neovascularization and rhegmatogenous retinal detachment with intravitreal antivascular endothelial growth factor during primary retinal detachment repair
por: Saurabh, Kumar, et al.
Publicado: (2018)

Trabeculectomy for neovascular glaucoma in proliferative diabetic retinopathy, central retinal vein occlusion, and ocular ischemic syndrome: Surgical outcomes and prognostic factors for failure
por: Senthil, Sirisha, et al.
Publicado: (2021)

Foveal neovascularization in combined branch retinal vein and artery occlusion
por: Romano, Francesco, et al.
Publicado: (2021)

Central retinal vein occlusion and branch retinal vein occlusion in the same eye
por: Sundar, M Dheepak, et al.
Publicado: (2019)

Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma
por: Mansour, Ahmad M., et al.
Publicado: (2014)

Clinical characteristics and antivascular endothelial growth factor effect of choroidal neovascularization in younger patients in Taiwan
por: Li, Yi-Hsuan, et al.
Publicado: (2015)

Anterior chamber depth and angle-closure glaucoma after central retinal vein occlusion
por: Wu, Shiu-Chen, et al.
Publicado: (2016)

Quantitative physiological measurements to evaluate the response of antivascular endothelial growth factor treatment in patients with neovascular diseases
por: Hong, In Hwan, et al.
Publicado: (2017)

Ten-year outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration
por: Chandra, Shruti, et al.
Publicado: (2020)

Pars plana vitrectomy combined with internal limiting membrane peeling for recurrent macular edema due to branch retinal vein occlusion after antivascular endothelial growth factor treatments
por: Shirakata, Yukari, et al.
Publicado: (2016)

Combined central retinal vein occlusion and branch retinal artery occlusion
por: Goel, Sugandha, et al.
Publicado: (2018)

Neovascular Events in Eyes with Central Retinal Vein Occlusion Undergoing Serial Bevacizumab or Ranibizumab Intravitreal Injections: A Retrospective Review
por: DeCroos, Francis Char, et al.
Publicado: (2014)

Ocular neovascularization in eyes with a central retinal artery occlusion or a branch retinal artery occlusion
por: Mason, John O, et al.
Publicado: (2015)

Early Onset of Neovascular Glaucoma After Intra-Arterial Thrombolysis for Central Retinal Artery Occlusion: A Possible Complication?
por: Furashova, Olga, et al.
Publicado: (2022)

Bilateral choroidal neovascularization associated with optic nerve head drusen treated by antivascular endothelial growth factor therapy
por: Delas, Barbara, et al.
Publicado: (2012)

Comparison of systemic conditions at diagnosis between central retinal vein occlusion and branch retinal vein occlusion
por: Cho, Bum-Joo, et al.
Publicado: (2019)

Central retinal vein occlusion and pseudoexfoliation syndrome
por: Karagiannis, Dimitrios, et al.
Publicado: (2015)

Metamorphopsia associated with central retinal vein occlusion
por: Manabe, Koichiro, et al.
Publicado: (2017)

Cytokines and Pathogenesis of Central Retinal Vein Occlusion
por: Noma, Hidetaka, et al.
Publicado: (2020)

Catastrophic Antiphospholipid Syndrome Presenting as Bilateral Central Retinal Artery Occlusions
por: Saraf, Steven S., et al.
Publicado: (2015)

Evaluation of Systemic Endothelial Dysfunction in Retinal Vein Occlusions
por: Bozkurt, Erdinc, et al.
Publicado: (2022)

ASSOCIATION BETWEEN ANATOMICAL AND CLINICAL OUTCOMES OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED WITH ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR
por: Nguyen, Vuong, et al.
Publicado: (2021)

Does Glaucoma Share Common Pathogenesis with Branch Retinal Vein Occlusion?
por: Han, Jong Chul, et al.
Publicado: (2016)

Parapapillary Choroidal Microvasculature Dropout in Branched Retinal Vein Occlusion and Glaucoma
por: Baek, Jiwon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4b1mf4d1n16sak2mukag1vifsu